ATLAS / Macro Radar / Reporting / IMA

ImageneBio, Inc. (IMA) reporting calendar

ImageneBio, Inc. files periodic reports with the SEC as IMA on Nasdaq. Atlas tracks 21 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
16 Jul 2026 – 29 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
21

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open IMA market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001193125-26-212073
10-K31 Dec 202510 Mar 202669 days0001193125-26-099434
10-Q30 Sep 202512 Nov 202543 days0001193125-25-275932
10-Q30 Jun 202524 Jul 202524 days0000950170-25-098414
10-Q31 Mar 20258 May 202538 days0000950170-25-066411
10-K31 Dec 20246 Mar 202565 days0000950170-25-034188
10-Q30 Sep 20247 Nov 202438 days0000950170-24-122818
10-Q30 Jun 20248 Aug 202439 days0000950170-24-093880
10-Q31 Mar 202413 May 202443 days0000950170-24-058715
10-K31 Dec 202312 Mar 202472 days0000950170-24-029651
10-Q30 Sep 20239 Nov 202340 days0000950170-23-061535
10-Q30 Jun 202310 Aug 202341 days0000950170-23-040943
10-Q31 Mar 202315 May 202345 days0000950170-23-021909
10-K31 Dec 202214 Mar 202373 days0000950170-23-007681
10-Q30 Sep 20227 Nov 202238 days0000950170-22-022323
10-Q30 Jun 202211 Aug 202242 days0000950170-22-016600
10-Q31 Mar 202212 May 202242 days0000950170-22-009446
10-K31 Dec 202117 Mar 202276 days0000950170-22-003998
10-Q30 Sep 202110 Nov 202141 days0000950170-21-003871
10-Q30 Jun 202112 Aug 202143 days0001564590-21-043997
10-Q31 Mar 202113 May 202143 days0001564590-21-027555

Source: SEC EDGAR company submissions for CIK 0001835579. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.